Insider trading · Q3 2026 · CIK 1590877

REGENXBIO Inc. (RGNX) insider trading.

In Q3 2026, insiders at REGENXBIO Inc. reported 15 non-derivative transactions on 9 Forms 3, 4 and 5: 2 open-market purchases worth $950K and 3 sales worth $718K.

Transactions
15
Purchases (P)
2
Sales (S)
3
Net shares, P minus S
44,109
Insiders
6
Last filed
2026-09-03

Insiders

InsiderRelationshipTransactionsBuysSales
Pakola SteveOfficer · Chief Medical Officer603
Ciongoli Gregory AustinDirector320
Simpson CurranDirector, Officer · Chief Executive Officer300
Chan MitchellOfficer · Chief Financial Officer100
Malzahn CraigOfficer · Chief Technology Officer100
Christmas Patrick J.Officer · Chief Strategy & Legal Officer100

Transactions

15 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-09-01Chan MitchellF (D)4,902$9.32122,815Form 4
2026-09-01Malzahn CraigF (D)234$9.3281,960Form 4
2026-08-27Ciongoli Gregory AustinP (A)53,407$9.36118,035Form 4
2026-08-26Ciongoli Gregory AustinP (A)49,196$9.1464,628Form 4
2026-08-25Ciongoli Gregory AustinA (A)15,432$015,432Form 4
2026-08-01Christmas Patrick J.F (D)4,699$9.69205,968Form 4
2026-08-01Pakola SteveF (D)7,468$9.69205,541Form 4
2026-07-02Pakola SteveS (D)2,161$13.64213,009Form 4
2026-07-02Pakola SteveM (A)2,161$7.86215,170Form 4
2026-07-01Simpson CurranF (D)6,818$13.09338,053Form 4
2026-07-01Pakola SteveS (D)36,725$12.86213,009Form 4
2026-07-01Pakola SteveM (A)36,725$7.86249,734Form 4
2026-06-30Simpson CurranA (A)1,453$10.18344,871Form 4
2026-06-29Pakola SteveS (D)19,608$11.04213,009Form 4
2025-12-31Simpson CurranA (A)951$7343,418Form 4

Transaction codes in this quarter

Get RGNX insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1590877&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · RGNX company page · REGENXBIO Inc. on SEC.gov

Questions

Are insiders buying or selling REGENXBIO Inc. (RGNX)?

In Q3 2026, insiders at REGENXBIO Inc. reported 15 non-derivative transactions on 9 Forms 3, 4 and 5: 2 open-market purchases worth $950K and 3 sales worth $718K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these REGENXBIO Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/rgnx.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.